000			01438 a2200385 4500
005			20250517082815.0
264		0	_c20161025
008			201610s 0 0 eng d
022			_a1471-2318
024	7		_a10.1186/s12877-016-0230-5 _2doi
040			_aNLM _beng _cNLM
100	1		_aClayton-Chubb, Daniel I
245	0	0	_aModerate dose melatonin for the abatement and treatment of delirium in elderly general medical inpatients: study protocol of a placebo controlled, randomised, double blind trial. _h[electronic resource]
260			_bBMC geriatrics _cFeb 2016
300			_a54 p. _bdigital
500			_aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdministration, Oral
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aCentral Nervous System Depressants _xadministration & dosage
650	0	4	_aDelirium _xdiagnosis
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDouble-Blind Method
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHumans
650	0	4	_aInpatients
650	0	4	_aLength of Stay
650	0	4	_aMale
650	0	4	_aMelatonin _xadministration & dosage
650	0	4	_aTreatment Outcome
700	1		_aLange, Peter W
773	0		_tBMC geriatrics _gvol. 16 _gp. 54
856	4	0	_uhttps://doi.org/10.1186/s12877-016-0230-5 _zAvailable from publisher's website
999			_c25782194 _d25782194